The company has always contributed to sharing clinical trials data and the results to relevant researchers and patients. The company believes that sharing of successful and unsuccessful results with other researchers can help in speeding up the process of finding new therapies. It can also help in reducing duplication and the findings of one trial can benefit the future researchers.
As announced, Sanofi will provide access to data and documents related to clinical trial. This would also include Clinical Study Reports (CSR), for clinical studies sponsored by Sanofi companies conducting clinical studies in humans. Also, the company would continue submitting results for publication irrespective of their outcomes. IGMPI
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…